Global Cardiac Implantable Electronic Devices (CIED) Market Growth 2024-2030

Global Cardiac Implantable Electronic Devices (CIED) Market Growth 2024-2030

Cardiac implantable electronic devices (CIEDs) are medical devices implanted in the body to manage and monitor heart function, primarily used to treat arrhythmias and heart failure. These devices include pacemakers, which regulate slow heart rhythms; implantable cardioverter-defibrillators (ICDs), which correct potentially life-threatening fast rhythms; and cardiac resynchronization therapy (CRT) devices, which improve the coordination of the heart's contractions. CIEDs continuously monitor the heart's activity and deliver electrical impulses or shocks when irregularities are detected, thereby maintaining proper heart function and improving patients' quality of life.

The global Cardiac Implantable Electronic Devices (CIED) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Cardiac Implantable Electronic Devices (CIED) Industry Forecast” looks at past sales and reviews total world Cardiac Implantable Electronic Devices (CIED) sales in 2023, providing a comprehensive analysis by region and market sector of projected Cardiac Implantable Electronic Devices (CIED) sales for 2024 through 2030. With Cardiac Implantable Electronic Devices (CIED) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiac Implantable Electronic Devices (CIED) industry.

This Insight Report provides a comprehensive analysis of the global Cardiac Implantable Electronic Devices (CIED) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiac Implantable Electronic Devices (CIED) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cardiac Implantable Electronic Devices (CIED) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiac Implantable Electronic Devices (CIED) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiac Implantable Electronic Devices (CIED).

United States market for Cardiac Implantable Electronic Devices (CIED) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Cardiac Implantable Electronic Devices (CIED) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Cardiac Implantable Electronic Devices (CIED) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Cardiac Implantable Electronic Devices (CIED) players cover Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Implantable Electronic Devices (CIED) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Permanent Pacemakers (PPMs)
Implantable Cardioverter Defibrillators (ICDs)
Cardiac Resynchronisation Therapy (CRT) Devices

Segmentation by Application:
GradeⅠ- Ⅳ
Grade Ⅱ- Ⅳ
Grade Ⅲ -IV

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Medtronic
Jarvik Heart
Abiomed
Boston Scientific
Impulse Dynamics
SynCardia
Berlin Heart
Covia Medica
V-Wave
Evaheart
BrioHealth Solutions
Hanyu Medical
NewMed Medical
Valgen Medtech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiac Implantable Electronic Devices (CIED) market?

What factors are driving Cardiac Implantable Electronic Devices (CIED) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiac Implantable Electronic Devices (CIED) market opportunities vary by end market size?

How does Cardiac Implantable Electronic Devices (CIED) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.